Arrowhead Pharmaceuticals (ARWR) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

ARWR is expected to report earnings to fall 30.85% to -95 cents per share on November 25

Arrowhead Pharmaceuticals ARWR Stock Earnings Reports

Q3'24

Est.

$-0.95

Q2'24

Missed

by $0.85

Q1'24

Missed

by $0.55

Q4'23

Missed

by $0.44

Q3'23

Missed

by $1.31

The last earnings report on August 08 showed earnings per share of -137 cents, missing the estimate of -52 cents. With 2.17M shares outstanding, the current market capitalization sits at 2.49B.

View a ticker or compare two or three

Compare

ARWR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ARWR
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ARWR (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of novel drugs to treat intractable diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

177 E. Colorado Boulevard

Phone

+1 626 304-3400

Employees

525

Web

https://www.arrowheadpharma.com